Table 2 Mean and standard deviation of EORTC QLQ-C30 & BR45 components for breast cancer patients at TASH, Addis Ababa, Ethiopia, 2021

Functional scale

Functional scale

Physical function (PF)

1–5

69.9 ± 19.1

Body image (BRBI)

9–12

78.64 ± 25.9

Role function (RF)

6, 7

79.7 ± 26.9

Sexual functioning (BRSEF)

14, 15

85.4 ± 22.0

Emotional function (EF)

21–24

73.3 ± 25.6

Sexual enjoyment (BRSEE)

16

85.5 ± 26.3

Cognitive function (CF)

20, 25

77.4 ± 23.6

Future perspective (BRFU)

13

57.1 ± 37.3

Social function (SF)

26, 27

68.9 ± 28.4

Breast satisfaction (BRBS) †

44, 45

71 ± 29.0

Global Health Status (GHS)

29, 30

65.6 ± 18.6

Symptom scale

Symptom scale

Fatigue (FA)

10, 12,18

34.3 ± 27.1

Systemic therapy side effects (BRST)

1–4, 6, 7, 8

29 ± 20.0

Nausea and vomiting (NV)

14, 15

23.8 ± 32.5

Breast symptoms (BRBS)

20–23

19.95 ± 25.3

Pain (PA)

9, 19

29.7 ± 27.1

Arm symptoms (BRAS)

17, 18, 19

22.7 ± 23.0

Dyspnea (DY)

8

16.1 ± 23.2

Upset by hair loss (BRHL)

5

41.8 ± 34.6

Insomnia (SL)

11

30.4 ± 33.2

Endocrine therapy scale (BRET)

2 4–26,33–39

17.8 ± 16.0

Appetite loss (AP)

13

37.4 ± 36.4

Endocrine sexual scale (BRES)

40–43

7.2 ± 14.7

Constipation (CO)

16

23.6 ± 31.0

Skin mucosis scale (BRSM)

27–32

14.3 ± 15.5

Diarrhoa (DI)

17

6.4 ± 18.4

Financial difficulties (FI)

28

50 ± 38.6